Adept Pharma and Bioscience Excellence Private Limited

Adept Pharma and Bioscience Excellence Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2012PTC081436 Incorporated 13 June 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2026
₹7.99 Cr
▲ 18% YoY
Net profit · FY 2026
₹93.38 Lakh
Net margin 11.7%
EBITDA · FY 2026
₹3.13 Cr
EBITDA margin 39.2%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.98 Cr
Issued & subscribed
Open charges
₹4.26 Cr
Satisfied ₹1 Cr
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings

About Adept Pharma and Bioscience Excellence Private Limited

Data last updated:

Adept Pharma and Bioscience Excellence Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 June 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2012PTC081436. Its GSTIN is 36AALCA1904F2ZY (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.98 Cr. It is led by directors including Arikatla Govardhana Reddy (Managing Director) and Arikatla Jyothiraditya Reddy.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 30 & 31 Survey No. 196 197 & 198 Rajiv Gandhi Nagar Moosapet Kukatpally, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2026, the company reported a revenue of ₹7.99 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹93.38 Lakh (net margin 11.7%) and EBITDA of ₹3.13 Cr (EBITDA margin 39.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 18% over five years.

The company is associated with 1 brand: Adept Pharma and Bioscience Excellence. As per MCA filings, the company has open charges of ₹4.26 Cr and satisfied charges of ₹1 Cr on record. Court records list 8 cases involving the company, including 4 filed by the company and 4 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.

Adept Pharma and Bioscience Excellence Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0007390). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adeptpharmabio.com.

Company details

CIN U24239TG2012PTC081436
Registration Number 081436
Incorporation Date 13 June 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0007390

CIN history

Adept Pharma and Bioscience Excellence has one previous CIN (Corporate Identification Number): U24239AP2012PTC081436. The current CIN is U24239TG2012PTC081436, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2012PTC081436Current
U24239AP2012PTC081436Previous

Recognitions & Rankings of Adept Pharma and Bioscience Excellence

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-TS-20-0007390

Contact details

Adept Pharma and Bioscience Excellence Private Limited's registered office is in Hyderabad, Telangana. Its website is adeptpharmabio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 30 & 31 Survey No. 196 197 & 198 Rajiv Gandhi Nagar Moosapet Kukatpally, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Pharma Contract R&D

To see the full contact details of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Comprehensive company report
Adept Pharma and Bioscience Excellence Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Adept Pharma and Bioscience Excellence operates one associated brand: Adept Pharma and Bioscience Excellence. Each brand links to its own profile.

BrandDescriptionWebsite
Offers chemical, instrumental, and microbiological testing for pharmaceutical sectors.adeptpharmabio.com

Business activity

The main business activity of Adept Pharma and Bioscience Excellence is professional, scientific and technical activities. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, scientific and technical activities72Scientific research and development

To see the full business activity and turnover split of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Financials of Adept Pharma and Bioscience Excellence Private Limited

FY 2026 filings available

Adept Pharma and Bioscience Excellence Private Limited reported revenue of ₹7.99 Cr (up 18% YoY) for FY 2026.

Revenue · FY 2026
₹7.99 Cr ▲ 18%
Net profit · FY 2026
₹93.38 Lakh margin 11.7%
EBITDA · FY 2026
₹3.13 Cr margin 39.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 9%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 9%
5 years · compounded
▲ 17%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 18% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹7.99 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.13 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹93.38 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin39.2%
Net Profit Margin11.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Board of directors of Adept Pharma and Bioscience Excellence Private Limited

Adept Pharma and Bioscience Excellence has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arikatla Govardhana ReddyManaging Director30 Sep 20215 Years 1 MonthsCurrent
Arikatla Jyothiraditya ReddyDirector28 Oct 20188 Years 0 MonthsCurrent
Pasam Narasimha ReddyDirector06 Jan 20224 Years 10 MonthsCurrent

Auditor

Adept Pharma and Bioscience Excellence Private Limited is audited by K. RAMBABU & CO for the financial year 2026.

Auditor firmFinancial yearFirm registration number
K. RAMBABU & COFY 2026224953

Shareholding

The shareholding of Adept Pharma and Bioscience Excellence Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4.26 Cr
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹2.76 Cr
Others₹1.49 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Feb 2025101080062Others₹64.3 LakhOpen
30 Sep 2024101001208Others₹85 LakhOpen
06 Apr 2023100715676Hdfc Bank Limited₹21.27 LakhOpen
09 Jul 2021100466077Hdfc Bank Limited₹2.55 CrOpen
30 Nov 2021100515001Others₹55.7 LakhSatisfied

To see the full charge records of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Adept Pharma and Bioscience Excellence Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.

Total deals
6
Secondary share transfers
4
Rights issue
1
Funding round
1
Disclosed funding
₹2.45 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2020Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals
Sep 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2019Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Sep 2018Funding round₹2.45 CrInvestors: 4 individuals

To see the full deal history of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Adept Pharma and Bioscience Excellence Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Adept Pharma and Bioscience Excellence has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AALCA1904F2ZYTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Adept Pharma and Bioscience Excellence Private Limited, buy the company report.

Recent activity

Adept Pharma and Bioscience Excellence Private Limited has 12 board changes on record since 2018: 3 appointments and 9 cessations. The latest: Pasam Narasimha Reddy was appointed as Director on 06 Jan 2022.

Filing
Adept Pharma And Bioscience Excellence Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
AGM
Adept Pharma And Bioscience Excellence Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 30 Nov 2021 via Charge ID 100515001 with Others was fully satisfied on 11 Jun 2025.
Charges
A charge with Others amounted to Rs. 0.64 Cr with Charge ID 101080062 was registered on 28 Feb 2025.
Charges
A charge with Others amounted to Rs. 0.85 Cr with Charge ID 101001208 was registered on 30 Sep 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 2.55 Cr registered on 09 Jul 2021 with Charge ID 100466077 was modified on 20 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100715676 was registered on 06 Apr 2023.
Appointed
Pasam Narasimha Reddy was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.56 Cr with Charge ID 100515001 was registered on 30 Nov 2021.
Appointed
Arikatla Govardhana Reddy was appointed as Managing Director.
Ceased
Arikatla Govardhana Reddy ceased to be Managing Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.55 Cr with Charge ID 100466077 was registered on 09 Jul 2021.

13 earlier events are in the company report.

Frequently asked questions

Adept Pharma and Bioscience Excellence is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 13 June 2012 (14+ years old) and is registered under CIN U24239TG2012PTC081436.

Adept Pharma and Bioscience Excellence has 3 current directors:

The latest financial statements of Adept Pharma and Bioscience Excellence on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Adept Pharma and Bioscience Excellence is 36AALCA1904F2ZY, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Adept Pharma and Bioscience Excellence is U24239TG2012PTC081436. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Adept Pharma and Bioscience Excellence has 8 court cases on record: 4 filed by the company and 4 filed against it. 2 are pending. Most are in the district courts.

Adept Pharma and Bioscience Excellence was incorporated on 13 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.

Adept Pharma and Bioscience Excellence has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.45 Cr; the latest was in March 2022.

Pasam Narasimha Reddy was appointed as Director on 06 Jan 2022. Arikatla Govardhana Reddy was appointed as Managing Director on 30 Sep 2021. Arikatla Govardhana Reddy ceased to be Managing Director on 20 Sep 2021. Adept Pharma and Bioscience Excellence has 12 board changes on record in total.

Yes, Adept Pharma and Bioscience Excellence is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0007390).